Schindler EAD

Headache Center of Excellence, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.

12 papers · ORCID

ArticlePsilocybin

Patient perspectives on research gaps in cluster headache.

Haghdoost F, Bahceci D, Delcourt C +15

Europe PMC2026
ArticlePsilocybin

Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.

Schindler EAD, Gottschalk CH, Pittman BP +1

Europe PMC2026
ArticlePsychedelics

Addressing blinding in classic psychedelic studies with innovative active placebos.

Aday JS, Simonsson O, Schindler EAD +1

Europe PMC2025
ArticlePsilocybin

Studying classic psychedelics for the management of headache disorders: Considerations for Veterans.

Schindler EAD, Sico JJ

Europe PMC2023
ArticlePsilocybin

The Potential of Psychedelics for the Treatment of Episodic Migraine.

Schindler EAD

Europe PMC2023
ArticlePsilocybin

Adapting psychedelic medicine for headache and chronic pain disorders.

Schindler EAD, Hendricks PS

Europe PMC2023
ArticlePsilocybin

Case report: Psychedelic-induced seizures captured by intracranial electrocorticography.

Blond BN, Schindler EAD

Europe PMC2023
ArticlePsilocybin

Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.

Rusanen SS, De S, Schindler EAD +2

Europe PMC2022
ArticlePsilocybin

Psychedelics as preventive treatment in headache and chronic pain disorders.

Schindler EAD

Europe PMC2022
ArticlePsilocybin

Psychedelics in the Treatment of Headache and Chronic Pain Disorders.

Schindler EAD

Europe PMC2022
ArticlePsilocybin

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.

Schindler EAD, Sewell RA, Gottschalk CH +6

Europe PMC2021
ArticlePsychedelics

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.

Schindler EAD, Wallace RM, Sloshower JA +1

Europe PMC2018